FDA Approves METFORMIN HYDROCHLORIDE — UNICHEM PHARMACEUTICALS (USA), INC.

UNICHEM PHARMACEUTICALS (USA), INC. has secured FDA approval for its preferred ANDA 207427 to manufacture generic metformin hydrochloride tablets, a move that strengthens the company’s contribution to the high-growth oral antidiabetic market. The approval is expected to provide the company with significant revenue opportunities as it competes against established players for a share of the massive, cost-sensitive diabetes treatment segment.